Trial
NCT00615784
Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Bexarotene
Why stopped
Study terminated. Eisai's Targretin acquired by another pharmaceutical company.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-17